Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

IL-1 and IL-7 help activate cells that boost hair follicle stem cell growth, aiding wound healing.

Calancardin B may help reduce inflammation in immune cells.

Identical p53 gene mutations in different cancers suggest the need for careful treatment.

Hair shaft miR-221 levels can help detect malignant melanoma.

Mcl-1 can activate Wnt signaling in skin cells, promoting growth and possibly cancer.

Blocking the CCR5 receptor may be a new way to treat hair loss from alopecia areata.

Alopecia areata patients have higher levels of certain immune receptors, suggesting new treatment possibilities.

EBV infection increases a specific keratin variant in carcinoma cells, possibly affecting cell structure and cancer progression.

Alopecia areata involves complex immune dysregulation, mainly driven by Th1 activity, suggesting broader treatment strategies.

SKH1 hairless mice have identifiable epidermal stem cells with specific markers.

Hair follicle stem cells reduced hair loss and inflammation in mice with a condition similar to human alopecia.

Deleting the MAD2L1 gene is tolerated in certain mouse cancer models.

Mouse hair follicle stem cells lose their ability to change into different cell types after being grown for a long time.

IL-15 is key for T cell function and could help improve treatments for immune-related diseases.

Targeting colon cancer stem cells might lead to better treatment results.

IL-15 promotes hair growth and protects hair follicles.

Four antibodies were developed to help study hair follicle cell differentiation.

Researchers found three types of melanocytes in developing mouse skin, each with different genes and locations.

Hair follicle stem cells can help repair spinal cord injuries and improve walking.

The study found markers indicating that cells responsible for hair color are differentiating in specific areas of the hair follicle.

Skin lymphoproliferative disorders are hard to diagnose and often linked to systemic diseases, but most have a good prognosis with accurate diagnosis.

Targeting androgen receptor signaling may improve acute myeloid leukemia treatment.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

Fibroblasts and myeloid cells in mouse skin wounds are diverse and can change into different cell types during healing.

CTCL patients can safely continue treatment during COVID-19 with proper safety measures.

Basal cell carcinomas and squamous cell carcinomas have different gene activity patterns, suggesting unique treatment approaches.

IL-9 increases skin cell movement but decreases their ability to invade, and this effect is controlled by cell contractility, not by MMPs.

Adding TERT and BMI1 to certain skin cells can improve their ability to create hair follicles in mice.